COO
The Cooper Companies, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.3% ·
aandelenstroom +5.3% ·
netto nieuwe posities -9.1%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 149 | +2 | 133.62M | $9.60B | +8 | −7 |
| Q1 2026 | 151 | +1 | 132.75M | $9.51B | +6 | −6 |
| Q4 2025 | 149 | -1 | 147.94M | $12.12B | +1 | −1 |
| Q3 2025 | 22 | -1 | 84.49M | $5.79B | n/a | −2 |
| Q2 2025 | 21 | 0 | 75.38M | $5.36B | +1 | −1 |
| Q1 2025 | 18 | -4 | 34.09M | $2.87B | n/a | −4 |
| Q4 2024 | 22 | +2 | 30.60M | $2.81B | +2 | n/a |
| Q3 2024 | 19 | +3 | 19.38M | $2.14B | +3 | n/a |
| Q2 2024 | 16 | n/a | 16.68M | $1.46B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 23.97M | -1.1% | $1.64B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 15.32M | -0.8% | $1.05B | 0.0% | ▼ Trim | 2 | SEC ↗ ×19 |
| 3 | Capital World Investors ✦ | 10.55M | +25.7% | $723.42M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passief) | 8.59M | -0.8% | $588.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.18M | +332.9% | $424.04M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 6 | Geode Capital Management ✦ (passief) | 5.30M | +1.9% | $362.11M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 3.80M | -42.0% | $260.34M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | JPMorgan Chase ✦ | 2.75M | n/a | $188.74M | 0.0% | n/c | 1 | SEC ↗ ×28 |
| 9 | Millennium Management ✦ | 2.18M | +11.6% | $149.32M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 2.11M | n/a | $144.75M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 11 | D. E. Shaw & Co. ✦ | 923.40K | +68.8% | $63.31M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 670.00K | +28.4% | $45.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 508.60K | n/a | $34.87M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | AQR Capital Management ✦ | 476.40K | +423.0% | $32.58M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 15 | Adage Capital Partners ✦ | 459.66K | +151.0% | $31.51M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 207.33K | -4.9% | $14.21M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 142.50K | -64.1% | $9.77M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 115.82K | +873.6% | $7.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 92.34K | -85.0% | $6.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 81.27K | +4.2% | $5.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 44.00K | 0.0% | $3.02M | 0.0% | Held | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 6.86K | +5.3% | $470,253 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $35.06M | was 0.0% |
| Glenview Capital | $19.97M | was 0.6% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 664 houders, 203.43M aandelen, $13.35B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 10.00K aand @ 54.93 · $549,320
Director · 10.00K aand @ 53.91 · $539,150
Director · 3.00K aand @ 54.29 · $162,870
Director · 7.00K aand @ 54.11 · $378,770
Director · 4.70K aand @ 53.18 · $250,000
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie